Home Journals Articles Updates About
CN
image
收藏切换
Analysis of chemical drugs applied for clinical trial for the treatment of COVID-19
收藏切换
PDF
Chao ZHANG1, Shu-bing CHEN2, Jie ZHANG1, Ying GUO2, *
Acta Pharmaceutica Sinica | 2020, 55(3) : 355 - 365
Less
收藏切换
Acta Pharmaceutica Sinica | 2020, 55(3): 355-365
• Focus on Anti Novel Coronavirus Drugs Research •
Analysis of chemical drugs applied for clinical trial for the treatment of COVID-19
Full
Chao ZHANG1, Shu-bing CHEN2, Jie ZHANG1, Ying GUO2, *
Affiliations
  • 1. National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
  • 2. Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2020-03-12 doi: 10.16438/j.0513-4870.2020-0151
Outline
收藏切换

The Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread throughout China and many other countries around the world. The antivirals are important measures to this epidemic; however, there is no drug approved for against coronavirus yet. With the continuously rising number of confirmed/suspected cases of COVID-19, it is urgent to obtain antiviral drugs for the clinical treatment. In response to this situation, drug repurposing strategy becomes one of the best approaches for anti-SARS-CoV-2 drug discovery. By retrieving the clinical trials registered in Chinese Clinical Trial Registry and ClinicalTrials.gov, a total of 14 chemical drugs were registered for COVID-19. In this review, we summarize and analyze the 14 drugs' indications, targets, and research basis related to the activities against viral infections, esp. coronavirus infections. We are making efforts to understand the evidence basis of these drugs for the treatment of SARS-CoV-2 infection applied by various research and clinical institutions in response to this COVID-19 outbreak, and also providing clues for quick response to possible epidemic in future and reasonable expansion of the indications of drugs.

coronavirus  /  SARS-CoV-2  /  COVID-19  /  clinical trial  /  drug repurposing
Chao ZHANG, Shu-bing CHEN, Jie ZHANG, Ying GUO. Analysis of chemical drugs applied for clinical trial for the treatment of COVID-19[J]. Acta Pharmaceutica Sinica, 2020 , 55 (3) : 355 -365 . DOI: 10.16438/j.0513-4870.2020-0151
Appendix
Less
Year 2020 volume 55 Issue 3
PDF
178
70
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-0151
  • Receive Date：2020-02-20
  • Online Date：2026-01-20
  • Published：2020-03-12
Article Data
Affiliations
History
  • Received：2020-02-20
  • Revised：2020-02-22
Funding
Affiliations
    1. National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
    2. Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-0151
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House